Challenges in Glioblastoma Surgical Removal
Biological Characteristics That Prevent Complete Resection
- Glioblastomas diffusely infiltrate surrounding tissues and frequently cross the midline to involve the contralateral brain, making it impossible to distinguish tumor margins from normal brain tissue during surgery 1
- Tumor cells have been found in the peritumoral edema, which corresponds to the T2-weighted MRI abnormalities, extending well beyond the contrast-enhancing portion visible on imaging 1, 3
- Unlike oligodendrogliomas which are often well-demarcated, glioblastomas lack distinct tumor margins, making it impossible to identify all infiltrating cells during surgery 2, 3
Imaging Limitations
- It is difficult to accurately assess the full extent of glioblastoma using CT or MRI scans, as the visible contrast enhancement primarily reflects blood-brain barrier disruption rather than the true tumor boundaries 1, 3
- The extent of tumor infiltration often extends beyond what can be visualized with current imaging techniques, leading to residual tumor cells after what appears to be a "complete" resection 3
Surgical Challenges
- While the goals of surgery include obtaining tissue for diagnosis, alleviating symptoms related to increased intracranial pressure, and increasing survival, the infiltrative nature of high-grade astrocytomas frequently renders gross total removal impossible 1, 3
- Attempting to remove all infiltrating tumor cells would require removing large volumes of functional brain tissue, resulting in unacceptable neurological deficits 3
Contrast with Other Brain Tumors
- Unlike glioblastomas, total resection is often possible for oligodendrogliomas because they typically occur in the frontal lobes and have distinct tumor margins 2, 4
- Low-grade oligodendrogliomas appear well-demarcated radiographically, while glioblastomas have poorly defined borders with surrounding brain tissue 4, 5
Clinical Implications
- Because of the impossibility of complete surgical removal, the standard of care for glioblastoma involves multimodal treatment including maximal safe surgical resection followed by radiation therapy and chemotherapy 6, 7
- Surgical resection alone leads to median survivals of only 3 to 6 months due to the inevitable recurrence from residual infiltrating cells 7